BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17317909)

  • 1. [Megachemotherapy and autologous hematopoietic stem cell transplantation in children with solid tumours excluding neuroblastoma--experience of Polish paediatric centres].
    Drabko K; Choma M; Zaucha-Prazmo A; Wójcik B; Gorczyńska E; Kałwak K; Turkiewicz D; Słociak M; Ussowicz M; Dyla A; Chybicka A; Styczyński J; Debski R; Wysocki M; Goździk J; Ratajczak M; Kowalczyk JR
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):785-92. PubMed ID: 17317909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-dose therapy followed by auto HSCT in children--with advanced neuroblastoma in four transplant centres in Poland].
    Zaucha-Prazmo A; Drabko K; Wójcik B; Choma M; Kałwak K; Gorczyńska E; Turkiewicz D; Słociak M; Ussowicz M; Dyla A; Chybicka A; Goździk J; Ratajczak M; Styczyński J; Debski R; Wysocki M; Kowalczyk J
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):775-84. PubMed ID: 17317908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Megachemotherapy and autologous stem cell transplantation in children with Ewing sarcoma - Polish experience].
    Drabko K; Zaucha-Prazmo A; Choma M; Wójcik B; Dyla A; Paździor D; Kałwak K; Chybicka A; Skoczeń S; Goździk J; Styczyński J; Wysocki M; Kowalczyk J
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1069-73. PubMed ID: 19531828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Megachemotherapy followed by autologous haematopoietic stem cell rescue in children with high risk CNS tumours].
    Drabko K; Wiśniewska-Slusarz H; Wójcik B; Choma M; Zaucha-Prazmo A; Kowalczyk JR
    Med Wieku Rozwoj; 2005; 9(3 Pt 2):439-47. PubMed ID: 16719156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Megachemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcoma.
    Drabko K; Zawitkowska-Klaczynska J; Wojcik B; Choma M; Zaucha-Prazmo A; Kowalczyk J; Gorczynska E; Toporski J; Kałwak K; Turkiewicz D; Chybicka A
    Pediatr Transplant; 2005 Oct; 9(5):618-21. PubMed ID: 16176419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
    Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D
    Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing's sarcoma.
    Drabko K; Raciborska A; Bilska K; Styczynski J; Ussowicz M; Choma M; Wojcik B; Zaucha-Prazmo A; Gorczynska E; Skoczen S; Wozniak W; Chybicka A; Wysocki M; Gozdzik J; Kowalczyk J
    Bone Marrow Transplant; 2012 Dec; 47(12):1530-4. PubMed ID: 22609883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk neuroblastoma patients.
    Molina B; Alonso L; Gonzalez-Vicent M; Andion M; Hernandez C; Lassaletta A; Cormenzana M; Lopez-Ibor B; Villa M; Molina J; Diaz MA
    Pediatr Hematol Oncol; 2011 Mar; 28(2):115-23. PubMed ID: 21299340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
    Avramova B; Jordanova M; Michailov G; Konstantinov D; Christosova I; Bobev D
    J BUON; 2006; 11(4):433-8. PubMed ID: 17309174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors.
    Diaz MA; Vicent MG; Madero L
    Bone Marrow Transplant; 1999 Dec; 24(11):1157-9. PubMed ID: 10642802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
    Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
    Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
    Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J
    Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Single and double high-dose chemotherapy with autologous stem cell transplantation in children with advanced solid tumors: first experiences].
    Kühne T; Staehelin F; Avoledo P; Tichelli A; Passweg J; Imbach P; Gratwohl A
    Schweiz Med Wochenschr; 2000 Mar; 130(12):419-25. PubMed ID: 10780056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melphalan combined with a carboplatin dose based on glomerular filtration rate followed by autologous stem cell rescue for children with solid tumours.
    Shaw PJ; Pinkerton CR; Yaniv I
    Bone Marrow Transplant; 1996 Dec; 18(6):1043-7. PubMed ID: 8971371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics and therapy outcome in children with stage IV Hodgkin's lymphoma--the experience of two oncological centres].
    Bień E; Stachowicz-Stencel T; Zawitkowska-Klaczyńska J; Adamkiewicz-Drozyńska E; Odój T; Połczyńska K; Mitura-Lesiuk M; Stefanowicz J; Sierota D; Szołkiewicz A; Birkholz D; Hennig M; Kowalczyk JR; Balcerska A
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):631-8. PubMed ID: 17317894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of selected endocrine complications in patients treated with auto- and allo-haematopoietic stem cell transplantation].
    Niedzielska E; Wójcik D; Barg E; Pietras W; Sega-Pondel D; Doroszko A; Niedzielska M; Skarzyńska M; Chybicka A
    Med Wieku Rozwoj; 2008; 12(3):761-6. PubMed ID: 19305027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS].
    Fröhlich B; Ahrens S; Burdach S; Klingebiel T; Ladenstein R; Paulussen M; Zoubek A; Jürgens H
    Klin Padiatr; 1999; 211(4):284-90. PubMed ID: 10472563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant neoplasms localised in the parameningeal region in children treated at two Polish oncological centres-diagnostic and therapeutic dilemmas].
    Bieań E; Irga N; Stachowicz-Stencel T; Stefanowicz J; Połczyńska K; Sierota D; Szołkiewicz A; Adamkiewicz-Drozyńska E; Birkholz D; Zawitkowska-Klaczytska J; Dudkiewicz E; Katski K; Nurzyńska-Flak J; Balcerska A; Stankiewicz C; Kowalczyk JR
    Med Wieku Rozwoj; 2005; 9(3 Pt 2):449-61. PubMed ID: 16719157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy.
    Valteau-Couanet D; Le Deley MC; Bergeron C; Ducassou S; Michon J; Rubie H; Le Teuff G; Coze C; Plantaz D; Sirvent N; Bouzy J; Chastagner P; Hartmann O
    Pediatr Blood Cancer; 2014 Jun; 61(6):977-81. PubMed ID: 23970413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive chemotherapy with stem cell support-experience in pediatric solid tumours.
    Pinkerton CR
    Bull Cancer; 1995; 82 Suppl 1():61s-65s. PubMed ID: 7626856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.